BIOMAT Database Logo BIOMAT Database Logo

HL-A antibodies and some immunological problems of pregnancy. 1971

G Imre, and T L Keserü, and A Maráz, and P Hetyei

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011250 Pregnancy Complications, Hematologic The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS. Complications, Hematologic Pregnancy,Hematologic Pregnancy Complications,Pregnancy Complications, Hematological,Pregnancy, Hematologic Complications,Complication, Hematologic Pregnancy,Complication, Hematological Pregnancy,Complications, Hematological Pregnancy,Hematologic Pregnancy Complication,Hematological Pregnancy Complication,Hematological Pregnancy Complications,Pregnancies, Hematologic Complications,Pregnancy Complication, Hematologic,Pregnancy Complication, Hematological
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D005260 Female Females
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group

Related Publications

G Imre, and T L Keserü, and A Maráz, and P Hetyei
[Pregnancy-induced leukocyte-(HL-A) antibodies].
June 1973, Archiv fur Gynakologie,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
HL-A antigens and some immunological parameters in psoriasis.
January 1974, Tissue antigens,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
Cytotoxic anti-HL-A antibodies in pregnancy.
January 1972, Acta medica Polona,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
[Immunological problems in pregnancy].
January 1968, Archivio di ostetricia e ginecologia,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
[IMMUNOLOGICAL PROBLEMS IN PREGNANCY].
May 1965, Orvosi hetilap,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
[HL-A-specific, C'-fixing antithrombocytic antibodies. II. Absorption and elution studies of pregnancy sera using HL-A-specific antibodies].
November 1971, Blut,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
SOME IMMUNOLOGICAL PROBLEMS IN SEPTICAEMIA.
February 1931, Canadian Medical Association journal,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
SOME IMMUNOLOGICAL PROBLEMS IN SEPTICAEMIA.
September 1930, British medical journal,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
[Immunological problems in endangered pregnancy].
April 1969, Ceskoslovenska gynekologie,
G Imre, and T L Keserü, and A Maráz, and P Hetyei
[Determination of anti-HL-A-antibodies in cytotoxic pregnancy sera].
August 1971, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
Copied contents to your clipboard!